Document Detail


Diurnal monitoring of blood pressure and the renin-angiotensin system in hypertensive patients on long-term angiotensin converting enzyme inhibition.
MedLine Citation:
PMID:  2170513     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The temporal blood pressure course and the diurnal profile of the renin-angiotensin system were examined in 13 patients with essential hypertension receiving hydrochlorothiazide and enalapril once daily. Blood samples were taken and blood pressure was measured before the habitual morning dose of hydrochlorothiazide and enalapril (at 8.00 a.m.) and at seven time points over the next 24 h. During the period of maximal effect of enalapril (from 11.00 a.m. to 2.00 p.m.), the increase in plasma renin concentration ranged from no change to an 800% increase. A negative correlation was observed between an increase in plasma renin and a decrease in immunoreactive plasma angiotensin II concentration (Spearman rank-order correlation coefficient = 0.83). Notably, the greatest changes in plasma renin and angiotensin II concentrations after enalapril were seen in those patients whose blood pressure fell most during the day. We conclude that hypertensive patients on long-term therapy with enalapril once daily vary widely in their between-dose biochemical response to the drug, and that there is a significant association between the responsiveness of the plasma renin-angiotensin system and the effect on 24 h blood pressure.
Authors:
N Gadsbøll; M Damkjaer Nielsen; J Giese; A Leth; H Lønborg-Jensen
Related Documents :
3518603 - Role of arginine vasopressin in regulation of systemic arterial pressure.
16907653 - Potential side effects of renin inhibitors--mechanisms based on comparison with other r...
23172433 - Rotating distraction osteogenesis to enlarge the skull space.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of hypertension     Volume:  8     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  1990 Aug 
Date Detail:
Created Date:  1990-11-14     Completed Date:  1990-11-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  733-40     Citation Subset:  IM    
Affiliation:
Department of Clinical Physiology and Nuclear Medicine, Glostrup Hospital, University of Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Blood Pressure / drug effects,  physiology
Circadian Rhythm / physiology
Drug Therapy, Combination
Enalapril / therapeutic use
Female
Humans
Hydrochlorothiazide / therapeutic use
Hypertension / drug therapy*,  physiopathology
Male
Middle Aged
Renin-Angiotensin System / drug effects,  physiology*
Time Factors
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 58-93-5/Hydrochlorothiazide; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Positive inotropic action, natriuresis and atrial natriuretic factor release induced by endothelin i...
Next Document:  A functional morphometric study of the cremaster muscle microcirculation in young spontaneously hype...